Innovative Therapeutics IVIVA Medical is leveraging cutting-edge technologies such as tissue engineering, 3D additive manufacturing, and stem cell biology to develop regenerative solutions for end-stage kidney disease, representing a significant opportunity to collaborate with advanced biotech and medical device providers.

Recognition & Awards Receiving the Phase 2 KidneyX Prize highlights IVIVA's innovative progress and public sector validation, making them a promising partner for government and grant-funded projects in regenerative medicine and organ replacement technologies.

Funding & Revenue With an estimated revenue between 10 and 25 million dollars, IVIVA is positioned as a growing player in biotech, offering opportunities for strategic partnerships, investments, or supply chain collaborations with established healthcare firms.

Recent Talent Expansion The hiring of new research staff demonstrates ongoing R&D expansion, providing opportunities to collaborate on cutting-edge research projects, technology development, and innovation initiatives in tissue regeneration and bioartificial organs.

Technology Stack & Infrastructure Utilizing diverse digital tools such as Google Tag Manager, Nginx, and PWA, IVIVA shows a focus on modern digital infrastructure, opening prospects for tech partnerships, platform development, and integrated biotech solutions.